Social Media and COVID-19
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT04367363|
Recruitment Status : Completed
First Posted : April 29, 2020
Last Update Posted : December 29, 2020
|Condition or disease||Intervention/treatment|
|Coronavirus Depression Anxiety Stress||Behavioral: Social media & news consumption|
|Study Type :||Observational|
|Actual Enrollment :||151 participants|
|Official Title:||Tracking WhatsApp Behaviors During a Crisis: A Longitudinal Observation of Messaging Activities During the COVID-19 Pandemic|
|Actual Study Start Date :||March 17, 2020|
|Actual Primary Completion Date :||May 7, 2020|
|Actual Study Completion Date :||May 31, 2020|
We plan to recruit a representative sample of the Singapore population.
Behavioral: Social media & news consumption
Daily reports of social media use and consumption, including reports on receiving and disseminating news articles related to the COVID-19 situation (e.g., how many messaging groups shared news on the outbreak, how many items related to the outbreak they forwarded to others, etc).
- WhatsApp usage [ Time Frame: 1 week, starting from date after baseline survey completion ]Participants were asked a series of questions daily related to their WhatsApp usage behaviors - in particular, their message-forwarding, personal chat and group chat behaviors.
- Changes in fear with regards the COVID-19 situation across 1 week [ Time Frame: 1 week, starting from date after baseline survey completion ]1 item each day on fear specifically of the COVID-19 situation (measured on a 4 point scale: min = 1, max = 4; higher scores indicating greater fear about the outbreak).
- Changes in amount of thinking about the COVID-19 situation across 1 week [ Time Frame: 1 week, starting from date after initial survey completion ]1 item each day on how much they thought about the outbreak that day (measured on a 5 point scale: min = 1, max = 5; higher scores indicating more thinking about the outbreak).
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04367363
|Singapore, Singapore, 138527|
|Principal Investigator:||Jean Liu, PhD||Yale-NUS College|